J Mesić

11 papers receiving 1.8k citations

J Mesić's Hit Papers

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate 2001 · 621 citations
6210+9+19Years since publication200400600

Peers

J Mesić
Comparison fields: 5 of 53
  • Otorhinolaryngology 195
  • Pulmonary and Respiratory Medicine 1.4k
  • Radiation 188
  • Cancer Research 180
  • Oncology 223
Replace R. L. Scotte Doggett with:
R. L. Scotte Doggett United States
Eugenio Borsatti Italy
Sharon Salenius United States
Gabriele Simontacchi Italy
R. Le Fur France
Ferrán Guedea Spain
Nicholas van As United Kingdom
Barry E. Epstein United States
Peter Ostler United Kingdom
Kinji Nishiyama Japan
J Mesić relative to R. L. Scotte Doggett United States R. L. Scotte Doggett's profile →
Citations per field
00.5×
R. L. Scotte Doggett · 1×
Citations per year

Countries citing papers authored by J Mesić

Since Specialization
Citations

This map shows the geographic impact of J Mesić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Mesić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Mesić more than expected).

Fields of papers citing papers by J Mesić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Mesić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Mesić. The network helps show where J Mesić may publish in the future.

Co-authors

The 25 scholars most cited alongside J Mesić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J Mesić Line = papers co-authored together J Mesić links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1
Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate
Hit paper breakdown →
2001621
2
Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.
Hit paper breakdown →
1997514
3 2001308
4 1981230
5 1997145
6 199269
7 198634
8 200331
9 199522
10 20008
11 19976
12 19991
13 19930

About J Mesić

J Mesić is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Epidemiology, Otorhinolaryngology and Genetics, having authored 13 papers that have together received 2.0k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (7 papers), Prostate Cancer Treatment and Research (4 papers), Colorectal and Anal Carcinomas (2 papers), Advanced Radiotherapy Techniques (1 paper), Head and Neck Cancer Studies (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Liver Disease Diagnosis and Treatment (1 paper) and Cervical Cancer and HPV Research (1 paper). The work is most often cited by research in Otorhinolaryngology (195 citations), Pulmonary and Respiratory Medicine (1.4k citations), Radiation (188 citations), Cancer Research (180 citations) and Oncology (223 citations). J Mesić has collaborated with scholars based in United States and Italy. Frequent co-authors include Miljenko V. Pilepich, David J. Grignon, C.A. Lawton, Mitchell Machtay, Kathryn Winter, Gerald E. Hanks, Gilbert H. Fletcher, Helmuth Goepfert, William T. Sause and Phillip Rubin. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, The Journal of Urology and Gynecologic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact